Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2003
11/27/2003WO2003072045A3 Treatment and prevention of aids progression and methods of using same
11/27/2003WO2003068940A3 Complexes and methods of using same
11/27/2003WO2003066661A3 Human dr4 antibodies and uses thereof
11/27/2003WO2003064622A3 Aggrecanase molecules
11/27/2003WO2003062270A3 Fluorescent protein from aequorea coerulscens and uses therof
11/27/2003WO2003062268A3 Corticotropin releasing factor receptor 2 agonists
11/27/2003WO2003057837A3 Methods for using anti-muc18 antibodies
11/27/2003WO2003035696A3 Humanized antibodies against icam-1, their production and uses
11/27/2003WO2003031578A3 Mammalian c-type lectins
11/27/2003WO2003030932A9 Attenuated mutant newcastle disease virus strains for in ovo vaccination, method for preparing and their use
11/27/2003WO2003029464A3 Genes associated with mast cell activation
11/27/2003WO2003024482B1 Crustaceans as production systems for therapeutic proteins
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003019137A3 Methods for screening antibody-producing cells on heterogenous antigen substrates
11/27/2003WO2003018636A3 Chimaeric peptides of insulin, their compositions and use in treating diabetes
11/27/2003WO2003013590A8 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
11/27/2003WO2003009817A3 Stable lyophilized pharmaceutical formulation of igg antibodies
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2003007881A3 Antibodies specific for nanotubes and related methods and compositions
11/27/2003WO2003001981A3 Method of promoting engraftment of a donor transplant in a recipient host
11/27/2003WO2002102299A3 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
11/27/2003WO2002097075B1 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
11/27/2003WO2002097041A3 Fusion proteins of biologically active peptides and antibodies
11/27/2003WO2002094881A3 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/27/2003WO2002092801A3 Methods and compositions for making emamectin
11/27/2003WO2002092771A3 Specific binding proteins and uses thereof
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002072632A3 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
11/27/2003WO2002068459A3 Non aggregating fluorescent proteins and methods for using the same
11/27/2003WO2002064791A3 Proteins and nucleic acids encoding same
11/27/2003WO2002063010A3 Method of producing recombinant antibodies against tumors
11/27/2003WO2002062302A3 Steroidal derivatives
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002050113A3 Interleukin-1 related gene and protein
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003WO2000062735A3 Treatment of neoplasms with viruses
11/27/2003US20030221215 Comprises nucleotide sequences for preventing oomycete infection of potato and/or tomato; disease resistant plants
11/27/2003US20030220489 29 human secreted proteins
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
11/27/2003US20030220475 Neutralizing immunogenic hev polypepetides
11/27/2003US20030220471 Extracellular proteins coded by nucleic acids, receptor or membrane-bound proteins, amino acid sequence lacking the signal peptide; use as drugs as thrombolytic agents, interferons, interleukins, erythropoietins
11/27/2003US20030220306 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder
11/27/2003US20030220231 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth
11/27/2003US20030220229 Modulate an immunological response by T cells of Type I diabetics which can be used as an indicator; derived from a region of proinsulin that spans the junction between the B chain and C peptide; inhibiting the development/progression
11/27/2003US20030219910 Immunoassay method/equipment, biological component measurable toilet, anti-albumin monoclonal antibody, cell strain producing the same, and albumin detection kit
11/27/2003US20030219885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2003US20030219876 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219861 Preparing libraries of chimeric immunoglobulins which demonstrate increased specificity and are comprised of framework regions (FR) and for use as diagnostic and therapeutic tools; genetic vaccines; gene therapy
11/27/2003US20030219860 Comprises nucleotide sequences coding novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents
11/27/2003US20030219855 Comprises genetically engineered transcription factor for identifying elements associated neuronal differentiation/determination
11/27/2003US20030219839 Using immunoglobulins for treating tumors; immunotherapy
11/27/2003US20030219836 Prognosticating probability of pregnancy via selectin concentration; in vitro fertilization
11/27/2003US20030219829 Heavy chain libraries
11/27/2003US20030219827 Comprises immunoglobulins which bind FMS-related tyrosine kinase 3 (Flt3) receptor for diagnosis and treatment of cancer; immunotherapy
11/27/2003US20030219821 Methods for identifying oncogenes and tumor-associated proteins
11/27/2003US20030219817 Preparing and screening immunoglobulin libraries; analyzing binding activity of affinity pairs; mimetic for treatment of autoimmune, cancer, viral and asthma disorders
11/27/2003US20030219786 Novel glycoproteins and methods of use thereof
11/27/2003US20030219766 Comprises nucleotide sequences coding human leukocyte antigen conjugate for use in diagnosis, prognosis and treatment of cell proliferative disorders; antiproliferative agents
11/27/2003US20030219752 Preparing immunoglobulin library; high throughput assay; immunoassays; immunotherapeutics and/or diagnostics; anticarcinogenic agents
11/27/2003US20030219741 Novel full-length cDNA
11/27/2003US20030219740 DNA sequences isolated from human colonic epithelial cells
11/27/2003US20030219739 Comprises muscle protein for treating and preventing of muscle atrophy
11/27/2003US20030219738 Nucleic acid and encoded zinc transporter protein entitled 108P5H8 useful in treatment and detection of cancer
11/27/2003US20030219737 Identifying bacterial holoenzyme for use in screening antibiotics and as tool in DNA synthesis/amplification
11/27/2003US20030219734 Calibrating immunoassay which detects natriuretic peptides for accurate diagnosis and prognosis of stroke, congestive heart failure, hypertensive, cardiovascular and nervous system disorders
11/27/2003US20030219733 Antibody gene transfer and recombinant AAV therefor
11/27/2003US20030219457 Derived from Clostridium proteins; immunogens; fusion proteins; vaccines
11/27/2003US20030219446 Ligand for CD28 receptor on B cells and methods
11/27/2003US20030219445 Reagents for cell selection and methods of use
11/27/2003US20030219443 Mycobacterium tuberculosis superoxide dismutase
11/27/2003US20030219442 Human monoclonal antibodies to influenza M2 protein and methods of making and using same
11/27/2003US20030219441 Combined methods and compositions for coagulation and tumor treatment
11/27/2003US20030219439 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders
11/27/2003US20030219438 Human antibodies that bind human TNFalpha
11/27/2003US20030219437 Administering antibodies used as antagonists to CD antigen ligands on the cells, for prophylaxis of cardiovascular, gastrointestinal or urogenital disorders
11/27/2003US20030219435 Method of reducing an immune response to a recombinant virus
11/27/2003US20030219434 Antibodies for cancer therapy and diagnosis
11/27/2003US20030219433 Anti-CD20 antibodies and fusion proteins thereof and methods of use
11/27/2003US20030219428 Deoxyribonuclease formed by genetic engineering, used for prophylaxis respiratory system disorders, lupus erythematosus and/or genetic disorders
11/27/2003US20030219426 Endostatins used as antiproliferative agents or angiogenesis inhibitors for prophylaxis of tumors, or as contraceptives
11/27/2003US20030219424 Polynucleotide codes for amino acid sequences used for medical diagnosis, prophylaxis autoimmune diseases, as antiallergens or antitumor agents
11/27/2003US20030219413 Method for overexpression of zwitterionic polysaccharides
11/27/2003US20030219411 Modulators of the function of FAS receptors and other proteins
11/27/2003US20030219403 Compositions and methods of tolerizing a primate to an antigen
11/27/2003US20030219382 Cancer-linked gene as target for chemotherapy
11/27/2003CA2830619A1 Glucan-based vaccines
11/27/2003CA2525646A1 Diagnosis of abnormal blood conditions based on polymorphisms in the glycoprotein vi gene
11/27/2003CA2511604A1 Treatment of cancer by the use of anti fas antibody
11/27/2003CA2486801A1 Method of prophylaxis of infection
11/27/2003CA2486583A1 Marker molecules associated with lung tumors
11/27/2003CA2486529A1 Novel phospholipases and uses thereof
11/27/2003CA2486464A1 Chimeric ige polypeptides and host cells
11/27/2003CA2486307A1 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
1 ... 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 ... 1494